Page last updated: 2024-11-07

n-benzyloxycarbonylprolylprolinal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-benzyloxycarbonylprolylprolinal: inhibitor of prolyl endopeptidase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122623
CHEMBL ID79993
SCHEMBL ID1219336
MeSH IDM0115944

Synonyms (46)

Synonym
brn 4821785
2-pyrrolidinecarboxylic acid, 2-((2-formyl-1-pyrrolidinyl)carbonyl)-, phenylmethyl ester, (s-(r*,r*))-
n-benzyloxycarbonyl-prolyl-prolinal
CHEMBL79993 ,
(s)-2-(2-formyl-pyrrolidine-1-carbonyl)-pyrrolidine-1-carboxylic acid benzyl ester
bdbm50038879
BRD-K60174629-001-02-2
BIO2_000265
BIO2_000745
BSPBIO_001545
IDI1_034015
n-benzyloxycarbonyl-l-prolyl-l-prolinal
z-pro-prolinal
DB03535
NCGC00163404-01
prolyl endopeptidase inhibitor ii
KBIOGR_000265
KBIO2_002833
KBIO3_000530
KBIO2_005401
KBIO3_000529
KBIOSS_000265
KBIO2_000265
NCGC00163404-02
n-benzyloxycarbonylprolylprolinal
HMS1989N07
HMS1361N07
HMS1791N07
88795-32-8
benzyl (2s)-2-[(2s)-2-formylpyrrolidine-1-carbonyl]pyrrolidine-1-carboxylate
unii-4ym8d0gkx6
4ym8d0gkx6 ,
CCG-207869
ORZXYSPOAVJYRU-HOTGVXAUSA-N
SCHEMBL1219336
HMS3402N07
z-prolyl-prolinal
(s)-benzyl 2-((s)-2-formylpyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate
benzyl (2s)-2-{[(2s)-2-formylpyrrolidin-1-yl]carbonyl}pyrrolidine-1-carboxylate
phenylmethyl (2s)-2-(((2s)-2-formyl-1-pyrrolidinyl)carbonyl)-1-pyrrolidinecarboxylate
1-pyrrolidinecarboxylic acid, 2-(((2s)-2-formyl-1-pyrrolidinyl)carbonyl)-, phenylmethyl ester, (2s)-
Q27094471
z-pro-pro-cho
DTXSID301008412
HY-134454A
CS-0168485
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency56.23410.141337.9142100.0000AID1490
Microtubule-associated protein tauHomo sapiens (human)Potency20.08500.180013.557439.8107AID1460; AID1468
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency7.94330.011212.4002100.0000AID1030
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency8.91250.035520.977089.1251AID504332
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency11.22020.354828.065989.1251AID504847
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prolyl endopeptidaseRattus norvegicus (Norway rat)IC50 (µMol)0.05400.00010.12430.3000AID161122
Prolyl endopeptidaseSus scrofa (pig)IC50 (µMol)0.00030.00020.01050.1300AID160369; AID242814
Prolyl endopeptidaseElizabethkingia meningosepticaIC50 (µMol)0.00130.00130.00130.0013AID356433
Prolyl endopeptidaseElizabethkingia meningosepticaKi0.00050.00050.00050.0005AID481410
Prolyl endopeptidaseHomo sapiens (human)IC50 (µMol)0.00190.00111.98969.7500AID1537274; AID160213
Prolyl endopeptidaseHomo sapiens (human)Ki0.00340.00000.00200.0080AID1539750; AID1539751; AID1539752; AID491557
Prolyl endopeptidaseMus musculus (house mouse)Ki0.00030.00030.00030.0003AID481397
Chymotrypsin-like elastase family member 1Homo sapiens (human)IC50 (µMol)0.05160.03000.04080.0516AID332190
Prolyl endopeptidaseBos taurus (cattle)Ki0.00030.00020.00030.0003AID1307743; AID481395
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
proteolysisProlyl endopeptidaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIChymotrypsin-like elastase family member 1Homo sapiens (human)
transcription by RNA polymerase IIChymotrypsin-like elastase family member 1Homo sapiens (human)
inflammatory responseChymotrypsin-like elastase family member 1Homo sapiens (human)
post-embryonic developmentChymotrypsin-like elastase family member 1Homo sapiens (human)
Wnt signaling pathwayChymotrypsin-like elastase family member 1Homo sapiens (human)
exocrine pancreas developmentChymotrypsin-like elastase family member 1Homo sapiens (human)
multicellular organism growthChymotrypsin-like elastase family member 1Homo sapiens (human)
regulation of cell population proliferationChymotrypsin-like elastase family member 1Homo sapiens (human)
regulation of cell differentiationChymotrypsin-like elastase family member 1Homo sapiens (human)
positive regulation of angiogenesisChymotrypsin-like elastase family member 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIChymotrypsin-like elastase family member 1Homo sapiens (human)
tissue remodelingChymotrypsin-like elastase family member 1Homo sapiens (human)
elastin catabolic processChymotrypsin-like elastase family member 1Homo sapiens (human)
pancreas morphogenesisChymotrypsin-like elastase family member 1Homo sapiens (human)
proteolysisChymotrypsin-like elastase family member 1Homo sapiens (human)
proteolysisProlyl endopeptidaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityProlyl endopeptidaseHomo sapiens (human)
protein bindingProlyl endopeptidaseHomo sapiens (human)
serine-type peptidase activityProlyl endopeptidaseHomo sapiens (human)
oligopeptidase activityProlyl endopeptidaseHomo sapiens (human)
serine-type endopeptidase activityChymotrypsin-like elastase family member 1Homo sapiens (human)
metal ion bindingChymotrypsin-like elastase family member 1Homo sapiens (human)
serine-type endopeptidase activityProlyl endopeptidaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
nucleusProlyl endopeptidaseHomo sapiens (human)
cytoplasmProlyl endopeptidaseHomo sapiens (human)
cytosolProlyl endopeptidaseHomo sapiens (human)
membraneProlyl endopeptidaseHomo sapiens (human)
cytosolProlyl endopeptidaseHomo sapiens (human)
extracellular spaceChymotrypsin-like elastase family member 1Homo sapiens (human)
cytoplasmProlyl endopeptidaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID481411Inhibition of POP in rabbit brain homogenate2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
AID491557Inhibition of prolyl oligopeptidase2010Bioorganic & medicinal chemistry, Jul-01, Volume: 18, Issue:13
Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide.
AID1539755Inhibition of recombinant human POP assessed as residence time pre-incubated for 30 mins before addition of ZGP-pNA substrate by absorbance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
AID160213In vitro inhibitory activity against purified prolyl endopeptidase (PEP) from canine brain.1994Journal of medicinal chemistry, Jun-24, Volume: 37, Issue:13
New potent prolyl endopeptidase inhibitors: synthesis and structure-activity relationships of indan and tetralin derivatives and their analogues.
AID160369In vitro inhibitory activity against prolyl oligopeptidase (POP) from pig brain expressed2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors.
AID242814In vitro inhibitory activity against porcine prolyl oligopeptidase by using 4 mM Suc-Gly-Pro-7-amido-4-methylcoumarin as substrate (pH 7.0) at 30 degree C for 60 min2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.
AID1537270Inhibition of human BuChE using butyrylthiocholine iodide as substrate measured for 1 min by Ellman's method2019Journal of natural products, 02-22, Volume: 82, Issue:2
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
AID1537274Inhibition of POP (unknown origin) using (Z)-Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by spectrophotometric method2019Journal of natural products, 02-22, Volume: 82, Issue:2
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
AID332190Inhibition of Flavobacterium meningosepticum PEP2002Journal of natural products, Jan, Volume: 65, Issue:1
A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex.
AID1539751Inhibition of recombinant human POP assessed as affinity constant of first step of the binding event pre-incubated for 2 hrs before addition of ZGP-pNA substrate and measured every 30 secs for first 60 mins followed by every 2 mins for next 5 hrs by dilut2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
AID481410Inhibition of Flavobacterium meningosepticum POP2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
AID1307743Inhibition of POP in bovine serum using Z-Gly-Pro-NH-Mec fluorimetric substrate2016Journal of medicinal chemistry, 05-12, Volume: 59, Issue:9
3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors.
AID1539756Inhibition of human recombinant FAP at 100 uM using fluorogenic DPP substrate1 relative to control2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
AID1537269Inhibition of human AChE using acetylthiocholine iodide as substrate measured for 1 min by Ellman's method2019Journal of natural products, 02-22, Volume: 82, Issue:2
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
AID481395Inhibition of bovine brain POP2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
AID1539753Inhibition of recombinant human POP assessed as association rate constant pre-incubated for 30 mins before addition of ZGP-pNA substrate by absorbance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
AID1896133Inhibition of POP (unknown origin)2022European journal of medicinal chemistry, Oct-05, Volume: 240Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
AID1539750Inhibition of recombinant human POP pre-incubated for 30 mins before addition of ZGP-pNA substrate by absorbance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
AID1537276Inhibition of GSK3B (unknown origin) at 10 uM relative to control2019Journal of natural products, 02-22, Volume: 82, Issue:2
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
AID481397Inhibition of mouse brain POP2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
AID1537277Permeability of the compound after 2.45 hrs by PAMPA2019Journal of natural products, 02-22, Volume: 82, Issue:2
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
AID356433Inhibition of Flavobacterium meningosepticum propyl endopeptidase2003Journal of natural products, Sep, Volume: 66, Issue:9
New bioactive diterpene polyesters from Euphorbia decipiens.
AID1539754Inhibition of recombinant human POP assessed as dissociation rate constant pre-incubated for 30 mins before addition of ZGP-pNA substrate by absorbance assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
AID161122Inhibitory activity was evaluated against Post-proline cleaving enzyme from rat cortex1996Journal of medicinal chemistry, Jun-07, Volume: 39, Issue:12
New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.
AID1539752Inhibition of recombinant human POP assessed as affinity constant of second step of inhibition pre-incubated for 2 hrs before addition of ZGP-pNA substrate and measured every 30 secs for first 60 mins followed by every 2 mins for next 5 hrs by dilution as2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (21.62)18.7374
1990's10 (27.03)18.2507
2000's9 (24.32)29.6817
2010's9 (24.32)24.3611
2020's1 (2.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.82 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (97.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]